Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abatacept, Abbott, abetted, abetting, Absent, acetaminophen, acid, acquiror, Actemra, Adalimumab, adapt, ADCC, afflict, aided, aiding, AIID, AlhydrogelTM, Amgen, amino, amplify, Anakinra, Anthrivig, AnthrivigTM, aquired, aquisition, arbitration, argument, Arzerra, ascending, assay, assemble, attach, attached, Baxter, Bayer, Belge, bendamustine, Benlysta, Bexxar, bifurcated, Bio, Biogen, Biotech, BMS, Boehringer, bone, bowel, BPCIA, breadth, caliber, Calmette, Campath, carbohydrate, cartilage, Centocor, Cephalon, Certolizumab, characteristic, chemotherapeutic, chemotherapy, Chimique, Chugai, Cimzia, CLL, closer, cohort, commensurate, commerical, Commitee, compelling, compliant, condensed, conflict, consituted, conspiracy, contrary, contrast, convened, counted, counteract, County, CVR, cyclophosphamide, cylcophosphamide, cytotoxic, cytotoxicity, daily, Datamonitor, deformity, degradation, detract, developmental, disaster, diversification, divest, division, domain, Draco, dynamic, effector, Eisai, Enbrel, EPDU, EPIC, episodic, escape, Etanercept, exit, extinguished, Facet, fashion, fatigue, fiduciary, fight, filer, fludarabine, freely, gap, Genentech, genetic, Genmab, Genzyme, glycosylation, grew, GSK, Guerin, GUP, headcount, hinge, HIPAA, Humira, hydroxychloroquine, Ib, Idec, immaterial, Immunoglobulin, immunopharmaceutical, inconvenient, inflammation, Infliximab, Ingelheim, insist, insistence, instance, invention, inventive, Japanese, Johnson, jointly, kidney, Kineret, King, leukemia, lieu, lymphoid, mAb, malignant, marrow, Marvin, membrane, merged, methotrexate, methylprednisolone, MHRA, misleading, mistakenly, Mitsubishi, Modular, MVAtor, myeloid, network, newly, NHL, niche, noninterference, nonrecurring, notably, NuThrax, NuThraxTM, oncology, opponent, opt, orderly, Orencia, organizational, Ortho, Otsuka, overseeing, palliative, Pegol, penalty, penetration, persuade, pharmacodynamic, Pharmacopoeia, PHS, predefined, PreviThrax, PreviThraxTM, profound, proportionally, PTE, RA, radiation, rata, receptor, recognizable, refractory, relapsed, Relocation, Remicade, remission, repeat, Reprioritization, reprioritize, retention, revert, Rituxan, rituximab, Roche, role, rulemaking, Schering, SCORPION, Seattle, Senegal, sequence, shortened, simple, Simponi, Singaporean, SLE, SMIP, SMIPtm, Society, solid, sooner, spectrum, Squibb, stake, stem, stored, straight, strictly, subpopulation, successor, supplementary, surgery, surpassed, sweeping, swollen, synergistic, synovium, Takeda, Tanabe, thereto, thickening, thin, thirteen, thought, Thravixa, ThravixaTM, timeframe, Tocilizumab, Transgene, transplant, transplantation, Treanda, TRICARE, Trubion, tumor, tune, UCB, uncontrollably, understated, unobservable, unrealized, upheld, uphold, uptake, VA, Vaxin, version, VHCA, Virbac, vivo, VRBPAC, Workshop, Zevalin
Removed:
account, acted, adjustment, afforded, allied, announce, asymptomatic, bacterial, Barre, Bell, bill, coli, collect, coma, composition, compound, confirm, constant, continuation, core, declaratory, decreasing, designing, Don, ectopic, Elsey, entailed, Epidemiological, erosive, evergreen, expensing, expert, fractionate, Frost, German, goal, Guillian, industrialized, infertility, initiating, injunctive, insolvency, introduction, invalidation, Keese, Kyle, leader, levofloxacin, marketplace, misrepresented, monotherapy, moved, nearest, NIH, nonvested, notifiable, ocular, palsy, pelvic, percent, positioned, pregnancy, prevalent, preventable, preventative, purify, reclassified, reject, relied, repository, reproductive, responding, room, rounded, scaled, segregated, sexually, shelf, signature, Singapore, statute, STM, subunit, suited, Sullivan, survived, tagged, terror, toxoid, trachoma, tract, undiluted, urogenital, usage, vesicular, volume, wake, withdrawn, withheld
Filing tables
Filing exhibits
Related press release
EBS similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-155311) of Emergent BioSolutions Inc. and Subsidiaries, |
(2) | Registration Statement (Form S-8 No. 333-139190) pertaining to the Employee Stock Option Plan, as amended and restated, the 2006 Stock Incentive Plan and individual director options agreements of Emergent BioSolutions Inc. and Subsidiaries, |
(3) | Registration Statement (Form S-8 No. 333-161154) pertaining to the Employee Stock Option Plan, as amended and restated, and the 2006 Stock Incentive Plan of Emergent BioSolutions, Inc., and |
(4) | Registration Statement (Form S-4 No. 333-169351) of Emergent BioSolutions Inc. and Subsidiaries. |
of our reports dated March 10, 2011, with respect to the consolidated financial statements of Emergent BioSolutions Inc. and Subsidiaries, and the effectiveness of Emergent BioSolutions Inc. and Subsidiaries’ internal control over financial reporting, included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
McLean, Virginia
March 10, 2011